Emergency department use by patients who received chimeric antigen receptor T cell infusion therapy

BACKGROUND: Chimeric antigen receptor T cell infusion (CAR T) therapy has revolutionized the treatment of hematologic malignancies, but treatment-related toxicities are of concern. Understanding the timing and reasons for which patients present to the emergency department (ED) after CAR T therapy ca...

Descripción completa

Detalles Bibliográficos
Autores principales: Lipe, Demis N., Qdaisat, Aiham, Chaftari, Patrick, Wattana, Monica K., Krishnamani, Pavitra P., Reyes-Gibby, Cielito, Yeung, Sai-Ching J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10064130/
https://www.ncbi.nlm.nih.gov/pubmed/37007139
http://dx.doi.org/10.3389/fonc.2023.1122329

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10064130/
https://www.ncbi.nlm.nih.gov/pubmed/37007139
http://dx.doi.org/10.3389/fonc.2023.1122329

Ejemplares similares